Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Carotid inflammation on FDG-PET is associated with lower cognitive performance in people with treated HIV infection.

AIDS (London, England)·2026
Same author

Provider Preferences About a Polypill for Heart Failure With Reduced Ejection Fraction: Development of a Multicenter Physician Survey Containing a Discrete Choice Experiment.

Journal of cardiac failure - intersections·2026
Same author

Heart Failure Risk in HIV: From Immunodeficiency to Metabolic Complexity.

Circulation. Heart failure·2026
Same author

Rationale, design, and baseline characteristicss of the effect of PCSK9 inhibition on cardiovascular risk in treated HIV infection: EPIC-HIV randomized clinical trial.

American heart journal·2026
Same author

Clonal Hematopoiesis in HIV and Atherosclerosis, Arterial Inflammation, and Lymph Node Metabolic Activity.

medRxiv : the preprint server for health sciences·2026
Same author

Low-Dose Colchicine Attenuates Clonal Hematopoiesis in COLCOT.

Circulation·2026

相关实验视频

Updated: May 29, 2026

High-throughput Detection Method for Influenza Virus
10:05

High-throughput Detection Method for Influenza Virus

Published on: February 4, 2012

心脏病专家需要了解的人类免疫缺陷病毒感染患者的情况

Priscilla Y Hsue1, David D Waters

  • 1Division of Cardiology, San Francisco General Hospital, Department of Medicine, University of California, San Francisco, CA, USA.

Circulation
|December 21, 2005
PubMed
概括
此摘要是机器生成的。

本案例研究考察了一名48岁的人类免疫缺陷病毒 (HIV) 感染男性的慢性胸痛的评估和管理,该男性患有显著的高脂血症. 它强调了这种复杂的患者形象所面临的诊断挑战和治疗考虑.

更多相关视频

Isolation and Identification of Extravascular Immune Cells of the Heart
08:24

Isolation and Identification of Extravascular Immune Cells of the Heart

Published on: August 23, 2018

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

相关实验视频

Last Updated: May 29, 2026

High-throughput Detection Method for Influenza Virus
10:05

High-throughput Detection Method for Influenza Virus

Published on: February 4, 2012

Isolation and Identification of Extravascular Immune Cells of the Heart
08:24

Isolation and Identification of Extravascular Immune Cells of the Heart

Published on: August 23, 2018

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

科学领域:

  • 心脏病学 心脏病学
  • 传染性疾病 传染性疾病
  • 临床医学 临床医学

背景情况:

  • 一名48岁的男性患有人类免疫缺陷病毒 (HIV) 感染,在肺炎后出现慢性胸痛.
  • 患者有高血压史和过去的吸烟,目前使用卡莱特拉和康比维尔.
  • 最初的脂质面板显示严重的高甘油三血 (935 mg/L) 和低的HDL (27 mg/L),总胆固醇为331 mg/L;LDL是不可计算的.

研究的目的:

  • 概述艾滋病毒感染患者患有复杂超脂血症的慢性胸痛的适当诊断评估.
  • 讨论这个患者的管理策略,考虑潜在的药物相互作用和心血管风险因素.

主要方法:

  • 病例报告详细说明了临床表现,病史和实验室发现.
  • 对免疫功能低下患者的胸痛诊断方法的审查.
  • 在HIV感染和抗逆转录病毒治疗的背景下讨论脂质管理指南.

主要成果:

  • 患者的表现表明胸痛的多因素病因,包括艾滋病毒和高脂血症加剧的潜在心脏病原因.
  • 严重的高甘油三血症具有显著的心血管风险,需要谨慎管理.
  • 抗逆转录病毒药物可能会导致血脂不良.

结论:

  • 综合评估至关重要,包括心脏检查和详细评估脂质异常.
  • 管理应解决心血管风险因素和潜在的药物相关副作用.
  • 为了在复杂的艾滋病毒病例中获得最佳的患者结果,需要量身定制的治疗策略.